Tanqi Lou Selected Research

Tanqi Lou Research Topics

Disease

10	IGA Glomerulonephritis (IGA Nephropathy) 01/2016 - 04/2006
9	Chronic Renal Insufficiency 12/2022 - 01/2013
7	Hypertension (High Blood Pressure) 12/2022 - 10/2016
6	Diabetic Nephropathies (Diabetic Nephropathy) 12/2022 - 01/2013
6	Proteinuria 06/2015 - 04/2006
3	White Coat Hypertension 12/2022 - 10/2016
3	Masked Hypertension 12/2022 - 10/2016
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2017
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2016 - 08/2014
3	Albuminuria 02/2016 - 01/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2022 - 12/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2017
2	Hyperglycemia 01/2018 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 09/2015 - 01/2013
2	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2013 - 02/2013
1	Pulmonary Hypertension 12/2020
1	Peritonitis 11/2020
1	Hyperuricemia 11/2020
1	Peritoneal Fibrosis 01/2019
1	Fibrosis (Cirrhosis) 11/2017
1	Kidney Diseases (Kidney Disease) 11/2017
1	Insulin Resistance 01/2017
1	Left Ventricular Dysfunction 10/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Hypertriglyceridemia 01/2016
1	Isolated Systolic Hypertension 01/2016
1	Diabetes Mellitus 06/2015
1	Hypercalcemia (Milk Alkali Syndrome) 01/2015
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 04/2013
1	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2013
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2013
1	Hypertrophy 01/2013
1	Atherosclerosis 01/2013
1	Lupus Nephritis 02/2011
1	Leukopenia 02/2011

Drug/Important Bio-Agent (IBA)

5	Serum AlbuminIBA 02/2017 - 02/2011
5	Immunoglobulin A (IgA)IBA 08/2011 - 04/2006
4	CreatinineIBA 09/2015 - 02/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2013
3	Prednisone (Sone)FDA LinkGeneric 04/2013 - 02/2011
3	Tacrolimus (Prograf)FDA LinkGeneric 04/2013 - 02/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
2	nephrinIBA 01/2018 - 04/2009
2	mahuang-tangIBA 03/2017 - 10/2016
2	Uric Acid (Urate)IBA 02/2017 - 01/2016
2	HomocysteineIBA 02/2017 - 10/2016
2	LipidsIBA 01/2016 - 04/2013
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 08/2014
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 02/2013 - 01/2013
2	Immunoglobulins (Immunoglobulin)IBA 05/2010 - 04/2009
1	Prostaglandins DIBA 12/2022
1	Long Noncoding RNAIBA 01/2022
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 12/2020
1	Urea (Carbamide)FDA LinkGeneric 11/2020
1	SodiumIBA 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2019
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2019
1	Sirtuin 1IBA 01/2018
1	MyokinesIBA 11/2017
1	Antihypertensive Agents (Antihypertensives)IBA 08/2017
1	Advanced Glycation End ProductsIBA 01/2017
1	Sirtuin 3IBA 01/2017
1	Silybin (Lagosa)IBA 01/2017
1	fasudil (AT 877)IBA 02/2016
1	PotassiumIBA 01/2016
1	DefensinsIBA 01/2016
1	Matrix Metalloproteinases (MMPs)IBA 06/2015
1	Sevelamer (RenaGel)FDA Link 01/2015
1	CalciumIBA 01/2015
1	Parathyroid Hormone (Parathormone)IBA 08/2014
1	Phosphates (Orthophosphate)IBA 08/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2013
1	CholesterolIBA 02/2013
1	SteroidsIBA 02/2013
1	OccludinIBA 01/2013
1	mouse MIRN29 microRNAIBA 01/2013
1	Valsartan (Vals)FDA Link 01/2013
1	AlbuminsIBA 01/2013
1	Simvastatin (Zocor)FDA LinkGeneric 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Cystatin CIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2011
1	Proteins (Proteins, Gene)FDA Link 02/2011
1	Carrier Proteins (Binding Protein)IBA 05/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2009
1	Leflunomide (Arava)FDA LinkGeneric 04/2006
1	Fosinopril (Monopril)FDA LinkGeneric 04/2006

Therapy/Procedure

3	Therapeutics 04/2013 - 02/2011
2	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2020 - 01/2017
2	Peritoneal Dialysis 01/2019 - 01/2017
2	Drug Therapy (Chemotherapy) 08/2017 - 04/2017
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 11/2020
1	Intraperitoneal Injections 01/2019
1	Chronotherapy 04/2017